Canadian patients and plan members are following a global trend, by demanding access to more personal information from their healthcare providers.
Insurers are hiking pooling costs, and we don’t blame them. Don’t kid yourself: if you were about to write your name underneath a policy, I’d wager that you too would increase premiums. Our block at The Beneplan Employee Benefits Co-operative was hit hard in 2015 by several biologic drug claims. While drug companies are falling over […]
You might have been reading a lot of stories about pharmaceutical companies increasing the price of brand and generic drugs tenfold. None more so perhaps than Martin Shkreli, the “Pharma Bro” and former CEO of Turing Pharmaceuticals, who raised the price of Daraprim, a drug used to treat HIV, by 5000%. But there is more […]
My name is Yafa, and I have a drug problem. Our block at The Beneplan Employee Benefits Co-operative was hit hard in 2015 by several biologic drug claims. While drug companies are falling over themselves to acquire the rights of biologic drugs, plan sponsors and advisors are scrambling to react to this new normal. Insurers […]
On September 10th, 2015, Health Canada approved Repatha, which is a prescription drug indicated for patients who have a genetic disorder which prevents them from properly metabolizing cholesterol. These patients would be best served by switching from statins to Repatha. Statins are cholesterol-lowering medications such as Lipitor, Crestor, atorvastatin, and many others. Repatha is a […]
You’ve probably heard of biologic drugs by now, which are highly expensive breakthrough drugs used to treat, and sometimes cure, illnesses. They are often described as ‘miracle drugs’, and can cost in the tens or hundreds of thousands of dollars per year. These biologic drugs are frequently covered by insurance companies on employee benefit plans, on a list of […]
Beneplan is proud to be introducing an exciting new plan option called the Reformulary drug plan.